Lars Fruergaard Jørgensen, the boss of Danish pharmaceutical giant Novo Nordisk, explained what impact the drugs can have on users weight in the long run ...

For the last few months, not a day has gone by where tariffs haven’t been on the tip of everyone’s tongue. The economic ...

The behavioural weight loss market continues to struggle in the shadow of the medical weight loss boom, as Weight Watchers ...

Lotte Bjerre Knudsen lives comfortably in this pleasant, but not showy, £900,000 apartment in central Copenhagen with her ...

For the last few months, not a day has gone by where tariffs haven’t been on the tip of everyone’s tongue. The economic uncertainty created by President Trump’s one-day-they’re-in-the-next ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, cut its ...

We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...

President Trump plans to announce the U.S. will refer to the Persian Gulf as the Gulf of Arabia or Arabian Gulf, according to ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound ...

An independent report on illicit trade has found that counterfeit medication to deal with issues like weight loss has been on ...